Connection
Michael Bishop to Cell Line, Tumor
This is a "connection" page, showing publications Michael Bishop has written about Cell Line, Tumor.
|
|
Connection Strength |
|
 |
|
 |
|
0.128 |
|
|
|
-
Bishop MW, Hutson PR, Hank JA, Sondel PM, Furman WL, Meagher MM, Navid F, Santana VM. A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors. MAbs. 2020 Jan-Dec; 12(1):1773751.
Score: 0.128